Fresh news on health and wellness in Saint Vincent and the Grenadines

Provided by AGP

St. Vincent & Grenadines Health Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on St. Vincent & Grenadines Health Press.

Press releases published on May 12, 2026

Nyxoah Reports First Quarter 2026 Financial and Operating Results
Nyxoah Publie ses Résultats Financiers et Opérationnels du Premier Trimestre 2026
LB Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update
Connect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
Nurix Therapeutics Announces Bexobrutideg Oral Presentation at the 2026 European Hematology Association Congress
Surrozen to Present at Upcoming Healthcare Investor Conference
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Neumora Therapeutics to Participate in 2026 RBC Capital Markets Global Healthcare Conference
Fractyl Health Reports First Quarter 2026 Financial Results and Business Updates
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update
Rezolute Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
Atea Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
BioStem Technologies to Present at the 16th Annual LD Micro Invitational
Rani Therapeutics to Participate in the H.C. Wainwright Annual BioConnect Investor Conference
Jushi Holdings Inc. Reports First Quarter 2026 Financial Results
Gyre Therapeutics Announces NMPA Acceptance of New Drug Application for F351 (hydronidone) for CHB-Induced Liver Fibrosis Treatment
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Share us

on your social networks:

Sign up for:

St. Vincent & Grenadines Health Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.